Ubs Group Ag Silo Pharma, Inc. Transaction History
Ubs Group Ag
- $527 Billion
- Q4 2024
A detailed history of Ubs Group Ag transactions in Silo Pharma, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 20,085 shares of SILO stock, worth $30,328. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,085Holding current value
$30,328% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding SILO
# of Institutions
16Shares Held
184KCall Options Held
0Put Options Held
0-
Jim Simons Renaissance Technologies LLC | New York, Ny37.5KShares$56,6250.0% of portfolio
-
Geode Capital Management, LLC Boston, MA34.9KShares$52,7710.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.3KShares$24,6640.0% of portfolio
-
Xtx Topco LTD London, X014.6KShares$21,9900.0% of portfolio
-
State Street Corp Boston, MA12.5KShares$18,8750.0% of portfolio
About Silo Pharma, Inc.
- Ticker SILO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 3,137,910
- Market Cap $4.74M
- Description
- Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company focuses on merging traditional therapeutics with psychedelic research for patients with depression, post-traumatic stress disorder, Alzheimer's, Parkinson's, and other rare neurological disorders. It has a scientific research agreement with the University ...